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Intracellular Ca2+ signaling is important in the regulation of several cellular processes
including autophagy. The endoplasmic reticulum (ER) is the main and largest intracellular
Ca2+ store. At the ER two protein families of Ca2+ release channels, inositol 1,4,5-
trisphosphate receptors (IP3Rs) and ryanodine receptors (RyRs), are expressed. Several
studies have reported roles in the regulation of autophagy for the ubiquitously expressed
IP3R. For instance, IP3R-mediated Ca2+ release supresses basal autophagic flux by
promoting mitochondrial metabolism, while also promoting the rapid initial increase in
autophagic flux in response to nutrient starvation. Insights into the contribution of RyRs
in autophagy have been lagging significantly compared to the advances made for IP3Rs.
This is rather surprising considering that RyRs are predominantly expressed in long-lived
cells with specialized metabolic needs, such as neurons and muscle cells, in which
autophagy plays important roles. In this review article, recent studies revealing roles for
RyRs in the regulation of autophagy will be discussed. Several RyR-interacting proteins
that have been established to modulate both RyR function and autophagy will also
be highlighted. Finally, the involvement of RyRs in neurodegenerative diseases will be
addressed. Inhibition of RyR channels has not only been shown to be beneficial for
treating several of these diseases but also regulates autophagy.
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INTRODUCTION
Intracellular Ca2+ signaling regulates a wide array of cellular processes such as cell division, muscle
contraction, memory formation, secretion, cell death, autophagy. . . (Berridge, 2001). Although
many different organelles are involved in Ca2+ signaling, the endoplasmic reticulum (ER) functions
as the main intracellular Ca2+ store. Within the lumen of the ER maintaining adequate Ca2+ levels
is essential to promote the correct folding of proteins. Failure to do so results in ER stress and
activation of the unfolded protein response (Mekahli et al., 2011; Carreras-Sureda et al., 2018). In
response to extracellular stimuli and agonists such as growth factors, hormones, neurotransmitters
and antibodies, Ca2+ release from the ER is a common extensively regulated event (Berridge, 2001).
Ca2+ responses can occur in highly localized microdomains, enabling intimate Ca2+ signaling
between different organelles like the ER and mitochondria and the ER and lysosomes (Laude and
Simpson, 2009; Kilpatrick et al., 2017; Pedriali et al., 2017) or they can spread across the entire cell
as Ca2+ oscillations and waves (Thul et al., 2008). Depending on the spatio-temporal profile of the
Ca2+ response, different processes are affected (Berridge et al., 2003). Long lasting Ca2+ oscillations,
for instance are known to promote cell survival by stimulating mitochondrial ATP production,
whereas excessive Ca2+ release is associated with cell death.
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The cellular components involved in ER Ca2+ dynamics
have been studied extensively and are well-characterized in
terms of function and regulation. Ca2+ is actively transported
into the ER via the sarco/endoplasmic reticulum Ca2+ ATPase
(SERCA; Vandecaetsbeek et al., 2011). The majority of Ca2+
release from the ER is mediated by two families of Ca2+-
permeable channels, inositol 1,4,5-trisphosphate (IP3) receptors
(IP3Rs; Foskett et al., 2007; Parys and De Smedt, 2012; Ivanova
et al., 2014; Mikoshiba, 2015) and ryanodine receptors (RyRs;
discussed in more detail later in this review article). IP3R are a
class of tetrameric intracellular Ca2+-release channels gated by
the second messenger IP3 (Parys and De Smedt, 2012). IP3R-
mediated Ca2+ signaling is present in virtually all cells and
is involved in the regulation of mitochondrial bioenergetics,
autophagy, cell death. . . (Cárdenas et al., 2010, 2016; Bultynck,
2016). Besides IP3Rs and RyRs, other proteins involved in ER
Ca2+ release or leak pathways are Bax Inhibitor-1, pannexin-1,
translocon, presenilins and Orai2 (Sammels et al., 2010b).
Apart from the ER, the mitochondria, lysosomes and the golgi
apparatus are known to sequester Ca2+ and contribute to Ca2+
signaling events (Raffaello et al., 2016). ER, mitochondria and
lysosomes are also important organelles in the regulation of
autophagy (La Rovere et al., 2016). It is therefore not surprising
that Ca2+ signaling is involved in the regulation of autophagy
(Decuypere et al., 2011a).
Ca2+ SIGNALING IN AUTOPHAGY
Autophagy is a degradation pathway responsible for maintaining
proper cell homeostasis. It removes damaged organelles or
helps cells cope with stress situations such as starvation, the
accumulation of unfolded proteins or infections. Three forms of
autophagy, micro-, macro- and chaperone-mediated autophagy,
are known to exist which all end with degradation in the
lysosomes (Decuypere et al., 2011a). Macroautophagy (from here
on referred to as autophagy) is a complex signaling pathway
involving several steps which guide the formation, elongation,
maturation and finally fusion of phagophores with lysosomes.
Several of these steps are Ca2+ dependent (Decuypere et al.,
2011a). Both stimulatory and inhibitory effects of Ca2+ on
autophagy have been described, which likely reflects a strict
spatio-temporal control of autophagy by Ca2+ signaling, recently
discussed in great detail in Bootman et al. (2018). In Brief, Ca2+
influx through voltage-gated Ca2+ channels has been shown
to inhibit autophagy by activating calpains that cleave ATG5,
which is important for autophagosome elongation (Williams
et al., 2008; Xia et al., 2010). As for stimulatory effects, several
studies have shown that increased cytosolic Ca2+ levels trigger
the activation of calmodulin, thus activating the AMP-activated
protein kinase (AMPK) via calmodulin kinase kinase β leading to
the inhibition of the mechanistic target of rapamycin (mTOR),
thereby inducing autophagy (Høyer-Hansen et al., 2007; Law
et al., 2010).
At the level of the ER, the IP3R was shown to be involved in
the regulation of autophagy. A continuous Ca2+ transfer from
the ER to the mitochondria is necessary to maintain proper
ATP production thereby inhibiting the activation of AMPK and
thus inhibiting autophagy (Cárdenas et al., 2010). In particular,
cancer cells appear to depend critically on these constitutive
ER-mitochondrial Ca2+ fluxes for their survival, since genetic or
pharmacological interference with such fluxes results in cancer
cell death (Bultynck, 2016; Cárdenas et al., 2016). For a more
in-depth review on the regulation of autophagy by IP3Rs, I would
like to refer to the following reviews (Parys et al., 2012; Kania
et al., 2017).
THE RYANODINE RECEPTOR (RyR)
RyRs are large (>500 kDa) ER-located Ca2+-permeable channels
of which three isoforms are known to exist. These channels form
and function as tetramers (Lanner et al., 2010). In contrast to the
ubiquitously expressed IP3Rs, RyRs have a distinct expression
pattern restricted to specific cell types such as T-cells and
excitable cells. Tissues expressing RyRs include heart, skeletal
and smooth muscle, brain, pancreas and the liver. From these
tissues, skeletal muscles, heart and neurons have the highest
RyR-expression levels (Lanner et al., 2010). More specifically,
skeletal muscle cells express large amounts of RyR1 (Lai and
Meissner, 1989), heart cells express RyR2 (Imagawa et al.,
1989) whereas all three RyR isoforms are expressed in different
areas of the brain (Martin et al., 1998). Given this rather
restricted expression pattern, it is not surprising that RyRs
are involved in several tissue-specific processes. In muscle and
heart cells, RyR1 and RyR2 are critically involved in excitation-
contraction coupling. In neurons long term potentiation and
long term depression are known to be at least in part RyR
dependent (Lanner et al., 2010). In the pancreas, RyRs are
involved in the secretion of insulin (Santulli et al., 2015) and
they also contribute to the development of bile acid-induced
acute pancreatitis (Husain et al., 2012). Physiological RyR
activators are Ca2+, cyclic-ADP ribose and NAADP (Meissner
et al., 1997; Kunerth et al., 2004; Gerasimenko et al., 2006).
However, it remains unclear whether NAADP activates RyRs
directly or via Ca2+-induced Ca2+ release (CICR) initiated at
the level of the lysosomes via NAADP-sensitive Ca2+ channels.
Pharmacologically RyRs can be activated by caffeine or low
ryanodine concentrations (nM range), locking the channel in a
sub-conductance state. Inhibition of RyRs can be obtained most
specifically via a high ryanodine conentrations (>20 µM) or with
dantrolene, a FDA-approved RyR blocker.
REGULATION OF THE RyR BY
PROTEIN-PROTEIN INTERACTIONS
RyR channels are regulated by many different cellular
components (Ca2+, Mg2+ and ATP), post translational
modifications and protein interactions (Lanner et al., 2010). In
this section, we will focus on a number of proteins that regulate
RyR-mediated Ca2+ release, which may potentially impact its
role in autophagy.
B-Cell Lymphoma (Bcl)-2 and Bcl-XL
The Bcl-2-protein family is well known as critical regulator
of apoptosis. This family consists of anti- and pro-apoptotic
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members, which are all characterized by the presence of at least
one and maximum four Bcl-2 homology (BH) domains (Letai,
2008). Anti-apoptotic Bcl-2 and Bcl-XL bind to pro-apoptotic
family members thereby preventing apoptosis-induction at the
mitochondria (Brunelle and Letai, 2009). In addition to the
regulation of apoptosis at the level of the mitochondria, Bcl-2
proteins have emerged as critical modulators of intracellular
Ca2+-transport systems and Ca2+ signaling events (Vervliet et al.,
2016). Both Bcl-2 and Bcl-XL have been extensively shown
to regulate IP3R-mediated Ca2+ release in several manners
(Chen et al., 2004; White et al., 2005; Hanson et al., 2008;
Rong et al., 2009; Eckenrode et al., 2010; Monaco et al., 2012;
Yang et al., 2016). Other Ca2+-signaling related targets of
anti-apoptotic Bcl-2 proteins include the plasma membrane
Ca2+ ATPase (Ferdek et al., 2012), SERCA (Dremina et al., 2004)
and the voltage dependent anion channel (VDAC; Shimizu et al.,
1999).
Recently, we have shown that both Bcl-2 and Bcl-XL
bind to and inhibit RyRs (Vervliet et al., 2014, 2015a). Both
proteins bound to a centrally located region on the RyR,
showing a striking similarity to the Bcl-2 binding site in the
central domain of the IP3R (Rong et al., 2009). The fourth
BH (BH4) domain of Bcl-2 and Bcl-XL was sufficient for
inhibiting RyR-mediated Ca2+ release. However, in full-size Bcl-
XL, also the BH3 domain and more specifically lysine 87, within
this domain, was important for targeting and inhibiting RyR
activity.
Presenilins
Presenilins form the catalytic subunit of γ-proteases. Substrates
of presenilins include notch and the amyloid precursor protein
(De Strooper et al., 2012). Presenilins are extensively studied for
their role in the development of Alzheimer’s disease (AD; Selkoe
and Hardy, 2016). In AD, presenilin mutations alter the cleavage
of the amyloid precursor protein, enhancing the formation
of pathological amyloid beta. This pathological amyloid beta
aggregates and forms plaques that are considered as an important
hallmark of the disease. Besides their actions as proteases,
presenilins are also known to play roles in Ca2+ signaling.
At the ER, presenilins have been implicated in inducing a
passive ER Ca2+ leak. It was proposed that these proteins
can form Ca2+-permeable pores potentially functioning as a
Ca2+-leak channel (Nelson et al., 2007). This unconventional
role for presenilins as Ca2+-leak channels also surfaced in
an unbiased systems biology approach using a collection of
siRNAs against Ca2+ regulators in living single cells (Bandara
et al., 2013). Presenilins also regulate IP3R channel function
and expression, which may contribute to their ER Ca2+ leak
properties (Kasri et al., 2006; Cheung et al., 2010; Wu et al.,
2013).
RyR expression and function is also dependent on presenilins.
Loss of presenilins in primary hippocampal neurons resulted in
a decrease in RyR expression and reduced RyR-mediated Ca2+
release, impairing pre-synaptic function (Wu et al., 2013). In
addition, an N-terminal fragment of presenilin-1 was shown to
inhibit RyR-mediated Ca2+ release, thereby directly regulating
RyR channel activity (Payne et al., 2013).
Polycystins (PC)
Polycystin (PC) 1 and 2 are important regulators of intracellular
Ca2+ signaling (Lemos and Ehrlich, 2018). Both PC1 and
PC2 are present at ER membranes, plasma membranes and cilia.
PC2 is a non-selective Ca2+-permeable cation channel, whereas
PC1 is important for PC2 localization and functioning (Tsiokas
et al., 2007; Delling et al., 2013). Loss of function of either
PC results in the development of polycytic kidney disease, a
disease characterized by aberrant intracellular Ca2+ signaling
leading to cyst growth and ultimately kidney failure (Torres
et al., 2007). These alterations in Ca2+ homeostasis are generally
attributed to loss of correct PC2 functioning or altered regulation
of different Ca2+ release channels by PC1 or PC2. The IP3R for
instance is regulated by both PC1 and PC2. PC1 interacts with
the IP3R thereby inhibiting IP3R-mediated Ca2+ release whereas
PC2 mediates the opposite effect on the IP3R (Li et al., 2005, 2009;
Sammels et al., 2010a).
In cardiomyocytes, RyR2 is regulated by PC2 (Anyatonwu
et al., 2007). It was shown that PC2 interacts with RyR2,
thereby inhibiting the channel. Knock out of PC2 resulted in
increased frequency of Ca2+ oscillations in the cardiomyocytes
and reduced the ER Ca2+ store content. Recently, it was shown
that a decrease in PC2 expression increased the expression
of RyR2 and SERCA2A in the heart while phosphorylated
phospholamban, a SERCA inhibitor in its non-phosphorylated
form, was decreased (Kuo et al., 2014). These results indicate that
PC2 regulates RyRs and Ca2+ signaling in the heart at multiple
levels.
THE RyR IN AUTOPHAGY
As mentioned above intracellular Ca2+ signaling is a versatile
regulator of autophagy. Major advances on the regulation
of autophagic flux by IP3Rs in nutrient-rich and starvation
conditions but also in response to treatments with for instance
rapamycin and resveratrol have been made (Kania et al., 2017).
However, our understanding of how RyR-mediated Ca2+ release
modulates the autophagic process has lagged compared to the
progress made for IP3Rs. A major issue for studying the role
of RyRs in autophagy has been the lack of easy-to-use cell
models that express RyRs endogenously. As autophagy is easily
influenced by many factors, expressing exogenous RyRs in cells
that do not have adequate RyR regulators, may alter autophagy
and other processes in a way that may have little physiological
relevance. Therefore, it is important to include model systems
expressing endogenous RyRs as well, to assess whether or not the
observations are replicable in a more physiological setting. That
being said, high RyR expression is observed in skeletal muscle,
heart and brain cells, which are all long-lived cells with specific
metabolic needs where autophagy plays important roles. In
addition, in these tissues RyR-mediated Ca2+ release is important
for performing several main functions like muscle contraction
and neuronal processes related to synaptic transmission and
memory formation. As RyRs are activated by CICR (Lanner
et al., 2010) they may serve to amplify Ca2+ signals or initiate
local Ca2+ signals that contribute to the sensitization of Ca2+-
handling systems promoting ER Ca2+ release thus modulating
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autophagy in a positive or negative way (Bootman et al., 2018).
Recently, a number studies have emerged, thereby revealing a
role for RyR channels in autophagy regulation.
First, the involvement of RyR3 in autophagic cell death,
a non-apoptotic form of programmed cell death driven by
autophagy (Edinger and Thompson, 2004), was demonstrated
in adult neuronal hippocampal stem cells (Chung et al., 2016).
The authors showed that in these cells, insulin withdrawal
increased the protein levels of LC3-II, an important autophagic
flux marker (Klionsky et al., 2016), suggesting a stimulation of the
autophagic flux. Insulin deprivation also upregulated RyR1 and
RyR3-mRNA correlating with increased Ca2+ release from the
ER, resulting in elevated cytosolic Ca2+ levels. Pharmacological
inhibition of RyRs using dantrolene could counteract the increase
in LC3-II levels. It is likely that RyR3 upregulation was a toxic
event that contributed to the observed autophagic cell death
induced by insulin withdrawal, as dantrolene could protect
against this, while caffeine had the opposite effect. These findings
were supported by CRISPR/Cas9-mediated knockout of RyR3 in
these neuronal stem cells, indicating that the RyR3-deficient stem
cells did not display the observed Ca2+ rises and were protected
from autophagic cell death in response to insulin withdrawal.
The effects of propofol, a commonly used intravenous
anesthetic known to induce neuronal damage and learning
deficits in rat (Milanovic et al., 2010; Karen et al., 2013), on
autophagy regulation have also been reported recently (Qiao
et al., 2017). Treatment of cortical progenitor cells with a high
dose of propofol resulted in cytotoxicity which was dependent
on both IP3R and RyR activation. The authors linked this
cytotoxicity to excessive autophagy activation, measured by
increased LC3-II levels after propofol treatment. Inhibition of
either IP3Rs or RyRs, using xestospongin C or dantrolene
respectively, reduced LC3-II to control levels and increased cell
viability. Suggesting RyRs are involved in the excessive induction
of autophagy by propofol.
In further recent work, we showed in HEK
RyR3-overexpression models, differentiated C2C12, cells and
dissociated hippocampal neurons that spontaneous RyR activity
inhibits basal autophagic flux (Vervliet et al., 2017). By blocking
RyR activity with either dantrolene or an inhibitory dose of
ryanodine, a reduction in LC3-II levels was observed. Including
bafilomycin A1, a lysosomal degradation blocker, under these
conditions increased LC3-II to similar levels as the control
conditions. This suggested that the observed decrease in LC3-II
levels upon RyR inhibition was due to an increased turnover of
autophagosomes. Early markers of autophagy induction such as
Beclin1, mTOR and AMPK activity were unaltered, confirming
that inhibiting sporadic RyR-mediated Ca2+ release increases
autophagic flux at the level of the lysosomes.
Although all three above studies reported a reduction in
LC3-II levels upon RyR inhibition seemingly contradicting
conclusions were drawn concerning the effects of RyR inhibition
on autophagic flux. In the first two studies a decrease in
autophagic flux was shown (Chung et al., 2016; Qiao et al., 2017),
whereas the last study suggests a stimulation of autophagic flux
upon RyR inhibition (Vervliet et al., 2017). A major difference
between these studies is whether or not autophagy stimulating
treatments or agents were used. The first two studies thus
addressed the role of RyRs in autophagy induction by an external
trigger, insulin deprivation or propofol treatment (Chung et al.,
2016; Qiao et al., 2017). The third study focused on basal
autophagy and spontaneous RyR activity (Vervliet et al., 2017).
Although the conclusions of these studies appear seemingly
contradictory, it is important to note that the role of Ca2+
signaling in basal vs. induced autophagy can be completely
different and even opposite which has been illustrated for IP3Rs
(Cárdenas et al., 2010; Decuypere et al., 2011b; Bootman et al.,
2018).
Another recent study showed that RyR inhibition using
dantrolene attenuated the observed alterations in autophagy in
neurons from a mouse model for Gaucher disease (Liou et al.,
2016). In this mouse model, neuronal RyR3 levels were reduced.
In addition, an increase in LC3-II levels was observed compared
to control mice. Treating these mice with dantrolene reduced
the LC3-II levels compared to the untreated controls, improved
mitochondrial function and overall survival rates. Strikingly,
dantrolene treatment resulted in an increase in RyR3 levels to
near WT levels. The authors concluded that dantrolene treatment
could largely reverse the observed defects in autophagy in these
mice, thereby normalizing basal autophagy.
In the heart RyR activity has been shown to regulate
mitochondrial metabolism. Downregulation of RyR2 in
cardiomyocytes resulted in decreased mitochondrial metabolism
decreasing ATP production (Bround et al., 2013). Reduction
of RyR2 triggered a hypoxia-like state thereby upregulating
hypoxia inducible factor (Hif1α), and presenilin-1 and -2, and
also increased autophagy induction. Reduced RyR2 levels lead
to a calpain 10-dependent form of non-apoptotic programmed
cell death, which has also been described to occur in pancreatic
β-cells treated with RyR inhibitors (Dror et al., 2008). This study
links RyR2-mediated Ca2+ release directly to mitochondrial
metabolism, ATP production and the induction of autophagy.
It is important to note that during ischemia reperfusion
RyR2 levels in the heart drop dramatically due to calpain activity,
proteasomal degradation and chaperone-mediated autophagy
(Pedrozo et al., 2013). This was proposed to be protective as
mitochondrial metabolism is slowed down, resulting in less
production of reactive oxygen species. This study also showed
that reducing RyR2 levels in cardiomyocytes triggers autophagy
and may thus confer additional protection for cardiomyocytes.
However, reduced RyR2 levels may impair cardiac contractility,
which could lead to heart failure.
RyR REGULATORS IN AUTOPHAGY
Bcl-2/Bcl-XL
Anti-apoptotic Bcl-2 proteins are known to inhibit autophagy
by sequestering Beclin 1 thereby inhibiting its pro-autophagic
actions (Pattingre et al., 2005). This interaction occurs via
the hydrophobic cleft of the Bcl-2 proteins and a BH3-like
domain in Beclin 1 (Pedro et al., 2015). As Bcl-2 binds to
Beclin 1 via its hydrophobic cleft and to the IP3R via its
BH4 domain, it is possible that Bcl-2 sequesters Beclin 1 at the
IP3R (Decuypere et al., 2011a). When Beclin 1 is then released
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from Bcl-2 it would be in close proximity of the IP3R, where
it may sensitize IP3R-mediated Ca2+ release thereby promoting
starvation-induced autophagy. At this point it is not known
whether Bcl-2 bound to RyRs is associated with Beclin 1 and thus
whether Beclin 1 can be found in a complex with RyRs. This is
possible since Bcl-2 binding to the RyRs is independent of its
hydrophobic cleft (Vervliet et al., 2015b). The hydrophobic cleft
of Bcl-2 proteins associated with RyRs might thus be available for
other BH3-domain-containing proteins, like Beclin 1. It will be of
interest to investigate whether Beclin 1 can bind to RyR channels
directly or indirectly (e.g., via Bcl-2) and whether such complex
formation impacts the function of the RyR in autophagy.
Bcl-2 and Bcl-XL both regulate IP3R-mediated Ca2+ release
(White et al., 2005; Rong et al., 2009; Decuypere et al.,
2011a; Monaco et al., 2012) and mitochondrial Ca2+ uptake
via VDAC (Shimizu et al., 1999, 2000; Arbel and Shoshan-
Barmatz, 2010). These proteins have a great impact on
mitochondrial bioenergetics and ATP production and may
also impact autophagy in this manner. As RyR-mediated Ca2+
release also regulates mitochondrial metabolism (Bround et al.,
2013), inhibition of RyRs via Bcl-2 and Bcl-XL potentially also
modulates autophagy through the regulation of RyR-mediated
Ca2+ transfer to the mitochondria in certain cells. In addition,
our data suggest that spontaneous RyR-mediated Ca2+ release
inhibits the autophagic flux at the level of the lysosomes (Vervliet
et al., 2017). As such, Bcl-2 and Bcl-XL could potentially promote
autophagy by inhibiting basal RyR function.
Presenilins
In the heart, it was shown that downregulation of RyR2 induced
a hypoxic-like condition associated with upregulation of
presenilins (Bround et al., 2013). Similar observations were made
in pancreatic β-cells where RyR inhibition resulted in depletion
of ATP and a presenilin-dependent induction of Hif1α (Dror
et al., 2008). This suggests a role for presenilins in regulating
mitochondrial metabolism under stress conditions.
AD-associated presenilin mutants have been shown to
increase IP3R-mediated Ca2+ release (Cheung et al., 2010).
This may have direct effects on mitochondrial metabolism,
energy production and autophagy (Bootman et al., 2018). RyR
expression levels and functions are also regulated by presenilins
(Payne et al., 2013; Wu et al., 2013). Knock down of presenilins
for instance, reduced RyR expression levels in hippocampal
neurons which in turn lowered RyR-mediated Ca2+ release in
these neurons (Wu et al., 2013). This decrease in RyR signaling
could potentially also regulate autophagic flux. However, at the
moment it is not known whether presenilins regulate autophagy
by targeting ER Ca2+ release channels.
Polycystins
PC1 and PC2 influence autophagy in a number of ways.
First, they both control the activity of mTOR, an important
kinase critically involved in autophagy induction (Laplante and
Sabatini, 2012). Overexpression of PC1 resulted in decreased
mTOR activity (Distefano et al., 2009) whereas either PC1 or
PC2 knock-down increased mTOR activity (Rowe et al., 2013;
Ravichandran et al., 2015; Orhon et al., 2016). In polycystic
kidney disease, mTOR signaling is increased which correlates
well with loss of function of PC1 and PC2 proteins (Shillingford
et al., 2006).
In human embryonic stem cell-derived cardiomyocytes,
PC2 was shown to regulate autophagy in a RyR2-dependent
manner (Lu et al., 2017). The authors showed that
PC2 knockdown reduced autophagic flux after glucose
deprivation. In contrast, PC2 overexpression was able to increase
autophagic flux under the same conditions. Glucose deprivation
was shown to increase the binding of PC2 with RyR2 which
was necessary for maintaining increased RyR2-mediated Ca2+
release after glucose deprivation. Finally, it was shown that
this PC2-RyR2-mediated Ca2+ signaling induced autophagy by
increasing AMPK activity, thereby inhibiting mTOR signaling.
THE RyR IN NEURODEGENERATIVE
DISEASES
Impaired or altered autophagic flux is a hallmark of several
neurodegenerative diseases but also of aging. This is a novel
topic in the field of autophagy and has recently been extensively
reviewed (Kroemer, 2015; Fîlfan et al., 2017; Gao et al., 2017;
Karabiyik et al., 2017; Liu et al., 2017; Moloudizargari et al.,
2017; Guo et al., 2018; Wang et al., 2018). Dysregulated RyR
expression/activity also play important roles in the development
of a number of neurodegenerative diseases. These emerging
roles for the RyR in several neurodegenerative diseases will be
highlighted in this part of the review article.
Alzheimer’s Disease (AD)
In the hippocampus of several AD mouse models, RyR3 levels
were shown to be upregulated (Chan et al., 2000; Chakroborty
et al., 2012; Oules et al., 2012). This results in excessive
RyR-mediated Ca2+ release, which underlies early pathological
events in AD. Inhibition of RyRs using dantrolene reduced
β- and γ-secretase activity and the phosphorylation of the
amyloid precursor protein thereby lowering amyloid beta plaque
formation (Chakroborty et al., 2012; Oules et al., 2012). It
must be noted that also negative effects of dantrolene-mediated
RyR inhibition in AD have been reported (Chami and Checler,
2014; Liu et al., 2014). This discrepancy was explained by
the time point at which these RyRs were inhibited. Using a
RyR3 knockout mouse model in a triple transgenic AD mouse
model background, it was shown that RyR3 activity may have a
protective effect during the early stages of the disease. Inhibiting
RyR3 at this point would thus promote disease progression.
In contrast, in older mice, RyR3 appears to promote disease
progression, suggesting that blocking the channel at this time
may decelerate the development of AD. Recently, it was shown
that post translational modifications of RyR2 occur in SH-SY5Y
cells overexpressing an AD linked amyloid precursor protein
mutation (Lacampagne et al., 2017). These modifications lead to
leaky RyR2 channels thereby elevating basal cytosolic Ca2+ levels.
Stabilizing this RyR2-mediated Ca2+ leak resulted in a decrease
in the processing of the amyloid precursor protein to amyloid
beta. Similar results were reported using AD mouse models in
which stabilizing leaky RyR2 channels by enhancing the binding
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of FKBP12.6 to RyR2 reduced amyloid beta plaque formation
and improved synaptic plasticity (Lacampagne et al., 2017).
Huntington’s Disease (HD)
RyR activity was also shown to be important in the development
of Huntington’s disease (HD; Chen et al., 2011). Inhibition of
RyRs by dantrolene in neurons obtained from a HD mouse
model was shown to reduce glutamate-induced excitotoxicity. In
addition, long term dantrolene feeding reduced the formation of
pathological huntingtin aggregates and neuronal loss. Whether
autophagy is also induced in these models after dantrolene
treatment was not studied. It has been shown that compounds
promoting autophagy by reducing IP3R-mediated Ca2+ release,
thereby inhibiting calpain activation, are beneficial for treating
HD (Williams et al., 2008). As calpain activity is critically
regulated by intracellular Ca2+, inhibition of RyRs could also
reduce calpain activity and in turn activate autophagy. However,
further research will be needed to elucidate whether or not RyRs
are involved in calpain-mediated autophagy regulation.
Parkinson’s Disease
Parkinson’s disease is characterized by a loss of dopaminergic
neurons, depletion of dopamine and mitochondrial dysfunction
resulting in oxidative and excitotoxic stress (Hirsch et al., 2013).
Recently, a new compound which showed neuroprotective effects
in dopaminergic neurons, was tested in a Parkinson’s disease
mouse model (Le Douaron et al., 2016). The neuroprotective
effects of this compound could be partially counteracted by
dantrolene, suggesting this compound operates in part by
activating RyR-mediated Ca2+ signaling. This is in agreement
with previous studies where caffeine and paraxanthine, a
metabolite of caffeine, were shown to promote dopaminergic
neuron survival and increased dopamine secretion (Guerreiro
et al., 2008; Xu et al., 2010). The neuro-protective effect of
paraxanthine was attributed to a mild activation of the RyR.
It may be important that RyRs were only mildly activated in
order to not sensitize these neurons to excitotoxic cell death,
as was illustrated in a Drosophila model of Parkinson’s disease
(Cassar et al., 2015). In this model, paraquat was used to induce
oxidative stress, mimicking the disease. Reducing the amount
of functional RyR channels in this model inhibited paraquat-
induced cell death. Oxidative stress is a potent RyR sensitizer
(Xu et al., 1998), which in turn could increase the sensitivity
to excitotoxic stimuli. Reducing the amount of functional RyR
channels may protect these cells from excitotoxic cell death.
Spinocerebellar Ataxia
Spinocerebellar ataxia (SCA) is a progressive neurodegenerative
disease of which several types are known to exist (Sun et al.,
2016). Activation of autophagy was shown to be beneficial in the
treatment of certain forms of SCA (Nascimento-Ferreira et al.,
2011). SCA type 2 and 3 are characterized by loss of Purkinje
FIGURE 1 | The interplay between ryanodine receptors (RyRs) and autophagy contributes to neuronal function and health. Recent studies linked RyR signaling to
autophagy suggest that RyR function and autophagy co-operate to maintain neuronal health (indicated in black). Disease causing mutant proteins, excitotoxicity and
aging are known causes of neurodegenerative diseases. It is becoming increasingly clear that during the onset of these diseases changes in RyR signaling and
autophagy occur contributing to the disease. These changes in RyR signaling may also affect the regulation of autophagy thereby accelerating even further the
disease progression (indicated in red). Because of the link between RyR-mediated Ca2+ signaling and autophagy, the RyR inhibitor dantrolene could potentially via
inhibiting RyRs also regulate autophagic flux. In this way, dantrolene may have multiple therapeutic effects (indicated in green). This may in part explain the beneficial
effects of dantrolene treatment for several neurodegenerative diseases.
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cells due to aggregation of neurotoxic disease-causing mutant
proteins. RyR activity is involved in the maturation of Purkinje
cells (Ohashi et al., 2014). Increasing RyRs or RyR activity could
potentially rescue the loss of Purkinje cells. This was explored in a
SCA3 mouse model where increasing serotonin and RyR levels in
the cerebellum rescued the loss of Purkinje cells associated with
the disease (Hsieh et al., 2017). In a mouse model for SCA2 the
mutant ataxin-2 protein was shown to trigger IP3R-mediated
Ca2+ release, which was amplified by RyR activity via CICR (Liu
et al., 2009). Treatment of these mice with dantrolene protected
Purkinje cells from excitotoxicity and cell death. These studies
indicate that the RyR may be a potential target for treating certain
types of SCA.
CONCLUSION
RyR signaling and autophagy are two factors critically linked
to the correct functioning and survival of neurons (Figure 1,
indicated in black). Studies showing how RyR-signaling regulates
autophagy have only recently emerged making this a novel
avenue in the autophagy field. In addition, several RyR-
interacting/-modulating proteins have known roles in the
regulation of autophagy which have not (yet) been linked to
regulating RyR-mediated Ca2+ release. It will be interesting
to see whether these interactors also influence autophagy by
modulating RyR-mediated Ca2+ release.
Alterations in RyR-mediated Ca2+ release and autophagy
have also been shown to contribute to several neurodegenerative
diseases. Disease causing mutant proteins, excitotoxicity and
aging are not only the cause for these diseases but also
change RyR function and autophagy. As RyR function and
autophagy are involved in maintaining neuronal health, changes
in these processes may result in aggravating disease progression
(Figure 1, indicated in red). Inhibition of RyR-mediated Ca2+
release has been shown to confer beneficial effects in treating
a number of these diseases. Several of the above mentioned
studies used the FDA-approved drug dantrolene in order to
block RyR-mediated Ca2+ release. An observation common in
the studies looking at how RyRs regulate autophagy, is that RyR
inhibition via dantrolene changes/normalizes autophagic flux.
This may in part underlie the beneficial effects of dantrolene in
several neurodegenerative diseases as by inhibiting RyR activity it
may also regulate autophagic flux indirectly (Figure 1, indicated
in green). However, more research will be needed to gain further
insights on the role of RyRs in regulating autophagy in the
context of neurodegenerative diseases.
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